ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01280565
Brief Title: A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Dacarbazine in the Treatment of Patients With Non-Resectable or Metastatic Stage 3 or Stage 4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of C-Kit

First Submitted : August 6, 2010
First Submitted that Met QC Criteria : January 19, 2011
First Posted : January 21, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : October 7, 2015
Last Update Posted : October 8, 2015 (Estimate)